Sunday, May 12, 2019

Novartis AG is offering price discounts in negotiations with U.S. health insurers on its gene therapy for spinal muscular atrophy (SMA), a treatment that could cost more than a million dollars, but the gesture comes with strings attached.


from Reuters: Health News https://reut.rs/2Hao93E

Related Posts:

  • LATEST HEALTH NEWSDyslexia affects 5 to 10% of school-aged children. from Health http://ift.tt/2swMIme … Read More
  • LATEST HEALTH NEWSSome hair loss is natural but factors such as stress, malnutrition or nutrient deficiencies, scalp infections, climate change, pollution, fatigue, hormonal imbalance and others can cause hair loss. from Health http://ift.tt/… Read More
  • LATEST HEALTH NEWSToothache is often caused by tooth decay or tooth abscess. from Health http://ift.tt/2ChpFeK … Read More
  • LATEST HEALTH NEWSTORONTO (Reuters) - Canopy Growth Corp, one of the world's biggest medical marijuana producers, now wants to take on the world's pharmaceutical giants. from Reuters: Health News http://ift.tt/2GhI5OY … Read More
  • LATEST HEALTH NEWSPYEONGCHANG, South Korea (Reuters) - Two Swiss freestyle skiers are the first athletes confirmed to have been hit by a highly contagious virus that causes vomiting and diarrhea at the Pyeongchang Winter Games, the Swiss Olymp… Read More

0 comments:

Post a Comment

Followers

Contact Form

Name

Email *

Message *

Popular Posts

FOLLOW BY EMAIL

Enter your email address:

Delivered by FeedBurner